TTNP

Titan Pharmaceuticals
TTNP

Overview Fund Trends Analyst Outlook
Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

17 hedge funds and large institutions have $179K invested in Titan Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TRCT
Tower Research Capital (TRC)
New York
+$390
2
Bank of America
Bank of America
North Carolina
+$28
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5

Top Sellers

1
Wells Fargo
Wells Fargo
California
-$24
Name Holding Trade Value Shares
Change 		Shares
Change %
Truist Financial
1
Truist Financial
North Carolina
$174K – – –
TRCT
2
Tower Research Capital (TRC)
New York
$3.99K +$390 +70 +11%
MA
3
MCF Advisors
Kentucky
$920 – – –
Bank of America
4
Bank of America
North Carolina
$95 +$28 +5 +42%
Group One Trading
5
Group One Trading
Illinois
$66 – – –
Osaic Holdings
6
Osaic Holdings
Arizona
$54 – – –
Morgan Stanley
7
Morgan Stanley
New York
$17 – – –
GWSA
8
Global Wealth Strategies & Associates
Colorado
$11 – – –
Wells Fargo
9
Wells Fargo
California
$6 -$24 -4 -80%
NA
10
NewEdge Advisors
Louisiana
$6 – – –
CIA
11
Cape Investment Advisory
Georgia
$6 – – –
NRG
12
Nemes Rush Group
Michigan
$6 – – –
UBS Group
13
UBS Group
Switzerland
$6 – – –
CSC
14
Caldwell Sutter Capital
California
$6 – – –
WIM
15
Westside Investment Management
California
$6 – – –
DJSG
16
D.J. St. Germain
Massachusetts
$6 – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
$5 +$5 +1 New